CONCLUSIONS These results suggest that further research is needed to understand the contribution of psychological, as much as medical, aspects to the overall outcome of the intervention. The present explorative study encourages a deeper investigations of psychological aspects of patients, in order to plan a tailored care path and to decide whether to suggest a psychological support, both before and after the intervention. Stored rice and rice products are prone to contamination by pathogenic fungi and bacteria such as Aspergillus niger, Bacillus cereus, and Paenibacillus amylolyticus. Treatment with antimicrobial essential oils (EOs) and irradiation are options to control spoilage organisms. Microbial samples with or without fumigation with an oregano/thyme EO mixture were irradiated at 0.5, 0.75, 1.0, 1.5, 2.0, 2.5, 3.0 and 3.5 kGy for calculation of a D10 value. https://www.selleckchem.com/products/oditrasertib.html The relative sensitivity was calculated as the ratio of D10 values for the irradiation plus oregano and thyme EO combination and irradiation alone treatments. In all cases, irradiation plus fumigation with the oregano and thyme EO mixture showed increased efficacy compared with irradiation alone. The relative sensitivity of γ-ray irradiation against A. niger was 1.22, 1.33, and 1.24 for radiation dose rates of 10.445, 4.558, and 0.085 kGy/h, respectively, however against B. cereus it was 1.28, 1.45, and 1.49, and against P. amylolyticus it was 1.35, 1.33, and 1.38, for respective γ-ray irradiation dose rates. The relative sensitivity of X-ray irradiation against A. niger, B. cereus, and P. amylolyticus was 1.63, 1.21, and 1.31, respectively, at the X-ray dose rate of 0.76 kGy/h. The results showed that the relative sensitivity of γ-ray irradiation was higher against the two bacteria than the fungus, whereas X-ray showed higher sensitivity against the fungus than the two bacteria. There was no consistent positive or negative relationship between dose rate and relative sensitivity. The results demonstrated the potential of an oregano and thyme EOs mixture as an antimicrobial agent and its efficacy to increase the radiosensitization of A. niger, B. cereus, and P. amylolyticus during γ-ray or X-ray irradiation treatments. Published by Elsevier Ltd.Anxiety disorders (ADs) are nervous system maladies involving changes in the amygdala synaptic circuitry, such as an upregulation of excitatory neurotransmission at glutamatergic synapses. In the field of nanotechnology, thin graphene oxide flakes with nanoscale lateral size (s-GO) have shown outstanding promise for the manipulation of excitatory neuronal transmission with high temporal and spatial precision, thus they were considered as ideal candidates for modulating amygdalar glutamatergic transmission. Here, we validated an in vitro model of amygdala circuitry as a screening tool to target synapses, towards development of future ADs treatments. After one week in vitro, dissociated amygdalar neurons reconnected forming functional networks, whose development recapitulated that of the tissue of origin. When acutely applied to these cultures, s-GO flakes induced a selective modification of excitatory activity. This type of interaction between s-GO and amygdalar neurons may form the basis for the exploitation of alternative approaches in the treatment of ADs. Breast cancer is the most common form of cancer among women worldwide. Early detection is central to improving disease outcomes. Three main screening methods - mammography, breast self-examination (BSE), and clinical breast examination (CBE) - have been developed and tested in Western nations. There is ongoing debate regarding the efficacy of BSE and CBE in terms of mortality reduction, and a number of international organizations no longer recommend them as screening methods. In technically less developed countries, however, where women are usually diagnosed with breast cancer at advanced stages and younger ages, the benefits of BSE and CBE might outweigh the harm and facilitate early detection of breast cancer. This paper reviews the history of BSE and CBE and discusses their value as early detection methods. It can contribute to informed decision-making by health policy-makers and clinicians who are involved in breast cancer screening in the developing world to improve women's well-being. BACKGROUND A prediction model with high sensitivity for the detection of negative axillary involvement can reduce additional axillary surgery in patients with ductal carcinoma in situ (DCIS) upstaged to invasive cancer while saving patients with pure DCIS from unnecessary axillary surgeries. Using a nationwide database, we developed and validated a scoring system for guidance in selective sentinel lymph node biopsy omission. PATIENTS AND METHODS A total of 41,895 patients with clinically node-negative breast cancer from the Korean Breast Cancer Registry were included. The study cohort was randomly divided for the development and validation of the prediction model. Missing data were filled in using multiple imputation. Factors that were significantly associated with axillary lymph node (ALN) metastasis in > 50% of datasets were included in the final prediction model. RESULTS The frequency of ALN metastasis in the total cohort was 24.5%. After multivariable logistic regression analysis, variables that were associated with ALN metastasis were palpability, multifocality, location, size, histologic type, grade, lymphovascular invasion, hormone receptor expression, and Ki-67 level. A scoring system was developed using these factors. The areas under the receiver operating characteristic curve for the scoring system was 0.750 in both training and validating sets. The cutoff value for performing sentinel lymph node biopsy was determined as a score of 4 to obtain prediction sensitivity higher than 95%. CONCLUSIONS A scoring system to predict the probability of ALN metastasis was developed and validated. The application of this system in the clinic may reduce unnecessary axillary surgeries in patients with DCIS and minimize additional axillary surgery for upstaged patients with invasive cancer.